Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU RER : revenue, balance sheet and financial ratios

PHARMACIE DU RER is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BRY SUR MARNE (94360), this company of category PME shows in 2024 a net income positive of 170 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DU RER (SIREN 523280873)
Indicator 2024 2023 2021 2020
Revenue N/C N/C N/C N/C
Net income 169 690 € 96 751 € 232 447 € 128 610 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE DU RER generates positive net income of 170 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 129 k€ -> 170 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

169 690 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 76%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

75.937%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

52.422%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

39.9%

Solvency indicators evolution
PHARMACIE DU RER

Sector positioning

Debt ratio
75.94 2024
2021
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average -17 pts over 3 years

In 2024, the debt ratio of PHARMACIE DU RER (75.94) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
52.42% 2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +25 pts over 3 years

In 2024, the financial autonomy of PHARMACIE DU RER (52.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 355.47. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

355.468

Liquidity indicators evolution
PHARMACIE DU RER

Sector positioning

Liquidity ratio
355.47 2024
2021
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent +47 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE DU RER (355.47) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHARMACIE DU RER in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DU RER is estimated at 2 368 997 € (range 1 649 732€ - 3 544 156€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1649k€ 2368k€ 3544k€
2 368 997 € Range: 1 649 732€ - 3 544 156€
NAF 5 année 2024

Valuation method used

Net Income Multiple
169 690 € × 14.0x = 2 368 998 €
Range: 1 649 733€ - 3 544 156€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU RER with other companies in the same sector:

Frequently asked questions about PHARMACIE DU RER

What is the revenue of PHARMACIE DU RER ?

The revenue of PHARMACIE DU RER is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DU RER profitable?

Yes, PHARMACIE DU RER generated a net profit of 170 k€ in 2024.

Where is the headquarters of PHARMACIE DU RER ?

The headquarters of PHARMACIE DU RER is located in BRY SUR MARNE (94360), in the department Val-de-Marne.

Where to find the tax return of PHARMACIE DU RER ?

The tax return of PHARMACIE DU RER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU RER operate?

PHARMACIE DU RER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.